Published by Pacific Edge Labs · Not affiliated with Ascend BioLabs
Pacific Edge LabsEvidence ReviewShop PEL ↗

PEL Evidence Review · September 15, 2026 (Pacific)

Ascend BioLabs NAD+ comparison: labels, sizes & COAs

Source-dated NAD+ comparison: specific PEL options, original sample documents, historical Ascend labels and unresolved differences.

Shop Pacific Edge Labs ↗Original PEL reports ↗
A Pacific Edge Labs publication. PEL is a competing research-material supplier and benefits from purchases through these links. This is a document-based comparison, not an independent customer review or the official Ascend website.

Comparison in brief

Compare a standalone NAD+ product separately from a multi-product bundle and from NADH or a precursor.

NAD+, not NADH or a precursor. Compare the same material and form.

Compare the actual label and evidence

FieldPEL sourceAscend BioLabs source
Material and labelled amountNAD+ · 500 mg / 1000 mgThe captured Semax–Selank–NAD bundle specified NAD+ at 500 mg.
Source dateLive product identity rechecked September 15, 2026 (Pacific); sample reports retain their own dates.Original plural-domain homepage captured September 11, 2026. Current product offer not verified.
Product optionsSeparate option links below.Do not infer a standalone offer from a bundle or a search snippet.
Report access4 displayed original links; sample matching still required.No current product-specific original authenticated for this comparison.
Current price and stockRead the exact live PEL option, including checkout terms.Not established by the archived observation.
Next unresolved questionDoes the selected option and supplied lot correspond to the document?Can the supplier provide the current label and its original lot-specific document?

Choose the exact PEL option

PEL labelled optionCurrent product source
1000 mgView this exact PEL option ↗
500 mgView this exact PEL option ↗

What the original PEL sample document says

NAD+ 1000mg · NAD019

Report 2606120161 names Freedom Diagnostics and is dated 2026-06-15.

Field stated by the sourceReported result
Identity (LC-MS)NAD+
Purity (HPLC-UV), analytical-results row99.59%
Net content average, as printed1016.26 mg

NAD019 is the 1000 mg-labelled sample. NAD020 identifies a different, 500 mg-labelled report. Keep lot, option and source distinct; neither report supports an NADH or precursor equivalence claim.

Open the complete original ↗ · Read the full source record and limitations

NAD+ 500mg · NAD020

Report 2606120157 names Freedom Diagnostics and is dated 2026-06-15.

Field stated by the sourceReported result
Identity (LC-MS)NAD+
Purity (HPLC-UV), analytical-results row99.88%
Net content average, as printed529.21 mg

Use this record for the stated NAD020 sample, not the separate 1000 mg-labelled option. The average is transcribed exactly as printed, without recalculating laboratory rounding.

Open the complete original ↗ · Read the full source record and limitations

These are readings of identified sample documents, not a new test, independent laboratory authentication or certification of every current shipping lot.

All displayed originals for this material

Questions answered

Can NAD+, NADH and an NAD precursor be compared as one material?

No. A similar name or research category does not establish the same material or format. Keep the 500 mg and 1000 mg NAD+ options separate and identify the sample on each report.

Does a report prove the current item will be identical?

No. The report describes its identified sample. Check the physical lot, selected amount and supplier documentation before extending the result to an order.

Where can I check the current Ascend website?

Use the dated website-status record. A DNS hold or connection failure does not establish product quality, fraud or an order outcome.

Keep the source and decision together

The historical observation above comes from ascendbiolabs.com, captured September 11, 2026. It is not a finding about the separate singular-name storefront.

Full PEL material guide · All material comparisons · Save a comparison worksheet

Reviewed September 15, 2026 (Pacific). PEL catalog identities were rechecked against the live public catalog. Historical Ascend observations retain their September 11, 2026 capture date; current offers and supplied-lot relationships are not inferred.

Watch the source walkthrough

Watch the captioned PEL demonstration with its complete transcript. Published by PEL, not an independent testimonial.

Shop Pacific Edge Labs ↗
Shop Pacific Edge Labs ↗